PubMed · 2019 · 28 citations · 28 references
MedicineNuclear MedicineRadiologyDiagnostic ImagingDiagnostic Nuclear MedicineDiagnostic RadiologyEndocrine ImagingEndocrine Tumor DiagnosisEndocrine Tumor ImagingEndocrine TumorsNeuroendocrine TumorsPositron Emission Tomography68Ga-dotatate ImagingEndocrine Pet ImagingFunctional ImagingHistopathologic ConfirmationRadiotracers Targeting Somatostatin ReceptorsSomatostatin Receptor ExpressionSomatostatin Receptor PetSomatostatin Receptor Scintigraphy
OBJECTIVES: Tc-Octreotide SPECT/CT, as well as CT/MRI. METHODS: Ga-DOTATATE PET/CT on the patient's management was assessed. RESULTS: Ga-DOTATATE PET/CT revealed more data in 44% and 36% of the patients, resulting in management modification in 24% and 20%, respectively. CONCLUSION: Ga-DOTATATE PET/CT led to change of management in up to one-fourth of the patients, especially in a sub-group re-evaluated for recurrence.
28
John J. Zaknun, Lisa Bodei, Jan Mueller‐Brand et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 809 citations · Full text
Medicine, Nuclear Medicine, Oncology +17
Murat Fani Bozkurt, Irene Virgolini, Soňa Balogová et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 488 citations · Full text
Medicine, Nuclear Medicine, Oncology +17
Irene Virgolini, Valentina Ambrosini, Jamshed Bomanji et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 447 citations